Yeast Strain GNL24/497 Safety Evaluation and Efficacy Validation on the Discomfort of Knee in Healthy Adults - Placebo-controlled Double-blind Randomized Clinical Trial -

Noriko Zamoto, Fumi Nihei, Akira Kubo, Yoshiyuki Saito, Kazunaga Yazawa

研究成果: Article

抄録

Objectives: The primary aim of this study was to analyze in detail the safety of the yeast strain GNL24/497. This was achieved by evaluating biochemical and physiological assay testing of the blood and urine after ingestion of 2500 mg/day (i.e. fivefold the daily dosage in healthy adults experiencing discomfort in the knee). To validate the effect on this discomfort after a 500 mg dose as previously reported for 4 weeks, our second aim was to evaluate whether the effect was altered when ingestion was maintained for 12 weeks. Methods: A placebo-controlled double-blind randomized clinical trial was conducted. Forty five healthy Japanese volunteers (range: 50-74 years old) were separated into three groups and each subjected to blood and urine testing once a month. To compare the yeast strain (500 mg per day) with the placebo for 12 weeks, Japanese Knee Osteoarthritis Measure (JKOM) and a 5 point scale questionnaire were used to evaluate 17 healthy Japanese adults once a month. Results The blood test and urinalysis results did not indicate any health hazard from ingestion of the yeast. The amount of change in VAS scores and the 5 point scale scores were significantly lower in the yeast group compared with the placebo group after 12 weeks ingestion (P<0.05). Conclusion It is suggested that oral intake of the yeast strain GNL24/497 is probably safe and effective in reducing discomfort in the knee in healthy adults. Specifically, it is indicated that the reported effects were maintained in the case of ingestion for a period of 12 weeks.

元の言語English
ページ(範囲)1037-1052
ページ数16
ジャーナルJapanese Pharmacology and Therapeutics
44
発行部数7
出版物ステータスPublished - 2016

Fingerprint

Knee
Randomized Controlled Trials
Eating
Yeasts
Placebos
Safety
Urine
Urinalysis
Knee Osteoarthritis
Hematologic Tests
Healthy Volunteers
Health

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

これを引用

Yeast Strain GNL24/497 Safety Evaluation and Efficacy Validation on the Discomfort of Knee in Healthy Adults - Placebo-controlled Double-blind Randomized Clinical Trial -. / Zamoto, Noriko; Nihei, Fumi; Kubo, Akira; Saito, Yoshiyuki; Yazawa, Kazunaga.

:: Japanese Pharmacology and Therapeutics, 巻 44, 番号 7, 2016, p. 1037-1052.

研究成果: Article

@article{03d423279c124eb386ad15fd4107ba56,
title = "Yeast Strain GNL24/497 Safety Evaluation and Efficacy Validation on the Discomfort of Knee in Healthy Adults - Placebo-controlled Double-blind Randomized Clinical Trial -",
abstract = "Objectives: The primary aim of this study was to analyze in detail the safety of the yeast strain GNL24/497. This was achieved by evaluating biochemical and physiological assay testing of the blood and urine after ingestion of 2500 mg/day (i.e. fivefold the daily dosage in healthy adults experiencing discomfort in the knee). To validate the effect on this discomfort after a 500 mg dose as previously reported for 4 weeks, our second aim was to evaluate whether the effect was altered when ingestion was maintained for 12 weeks. Methods: A placebo-controlled double-blind randomized clinical trial was conducted. Forty five healthy Japanese volunteers (range: 50-74 years old) were separated into three groups and each subjected to blood and urine testing once a month. To compare the yeast strain (500 mg per day) with the placebo for 12 weeks, Japanese Knee Osteoarthritis Measure (JKOM) and a 5 point scale questionnaire were used to evaluate 17 healthy Japanese adults once a month. Results The blood test and urinalysis results did not indicate any health hazard from ingestion of the yeast. The amount of change in VAS scores and the 5 point scale scores were significantly lower in the yeast group compared with the placebo group after 12 weeks ingestion (P<0.05). Conclusion It is suggested that oral intake of the yeast strain GNL24/497 is probably safe and effective in reducing discomfort in the knee in healthy adults. Specifically, it is indicated that the reported effects were maintained in the case of ingestion for a period of 12 weeks.",
keywords = "Discomfort, Japanese Knee Osteoarthritis Measure (JKOM), Knee, Safety, Yeast",
author = "Noriko Zamoto and Fumi Nihei and Akira Kubo and Yoshiyuki Saito and Kazunaga Yazawa",
year = "2016",
language = "English",
volume = "44",
pages = "1037--1052",
journal = "Japanese Pharmacology and Therapeutics",
issn = "0386-3603",
publisher = "Life Science Publishing Co. Ltd",
number = "7",

}

TY - JOUR

T1 - Yeast Strain GNL24/497 Safety Evaluation and Efficacy Validation on the Discomfort of Knee in Healthy Adults - Placebo-controlled Double-blind Randomized Clinical Trial -

AU - Zamoto, Noriko

AU - Nihei, Fumi

AU - Kubo, Akira

AU - Saito, Yoshiyuki

AU - Yazawa, Kazunaga

PY - 2016

Y1 - 2016

N2 - Objectives: The primary aim of this study was to analyze in detail the safety of the yeast strain GNL24/497. This was achieved by evaluating biochemical and physiological assay testing of the blood and urine after ingestion of 2500 mg/day (i.e. fivefold the daily dosage in healthy adults experiencing discomfort in the knee). To validate the effect on this discomfort after a 500 mg dose as previously reported for 4 weeks, our second aim was to evaluate whether the effect was altered when ingestion was maintained for 12 weeks. Methods: A placebo-controlled double-blind randomized clinical trial was conducted. Forty five healthy Japanese volunteers (range: 50-74 years old) were separated into three groups and each subjected to blood and urine testing once a month. To compare the yeast strain (500 mg per day) with the placebo for 12 weeks, Japanese Knee Osteoarthritis Measure (JKOM) and a 5 point scale questionnaire were used to evaluate 17 healthy Japanese adults once a month. Results The blood test and urinalysis results did not indicate any health hazard from ingestion of the yeast. The amount of change in VAS scores and the 5 point scale scores were significantly lower in the yeast group compared with the placebo group after 12 weeks ingestion (P<0.05). Conclusion It is suggested that oral intake of the yeast strain GNL24/497 is probably safe and effective in reducing discomfort in the knee in healthy adults. Specifically, it is indicated that the reported effects were maintained in the case of ingestion for a period of 12 weeks.

AB - Objectives: The primary aim of this study was to analyze in detail the safety of the yeast strain GNL24/497. This was achieved by evaluating biochemical and physiological assay testing of the blood and urine after ingestion of 2500 mg/day (i.e. fivefold the daily dosage in healthy adults experiencing discomfort in the knee). To validate the effect on this discomfort after a 500 mg dose as previously reported for 4 weeks, our second aim was to evaluate whether the effect was altered when ingestion was maintained for 12 weeks. Methods: A placebo-controlled double-blind randomized clinical trial was conducted. Forty five healthy Japanese volunteers (range: 50-74 years old) were separated into three groups and each subjected to blood and urine testing once a month. To compare the yeast strain (500 mg per day) with the placebo for 12 weeks, Japanese Knee Osteoarthritis Measure (JKOM) and a 5 point scale questionnaire were used to evaluate 17 healthy Japanese adults once a month. Results The blood test and urinalysis results did not indicate any health hazard from ingestion of the yeast. The amount of change in VAS scores and the 5 point scale scores were significantly lower in the yeast group compared with the placebo group after 12 weeks ingestion (P<0.05). Conclusion It is suggested that oral intake of the yeast strain GNL24/497 is probably safe and effective in reducing discomfort in the knee in healthy adults. Specifically, it is indicated that the reported effects were maintained in the case of ingestion for a period of 12 weeks.

KW - Discomfort

KW - Japanese Knee Osteoarthritis Measure (JKOM)

KW - Knee

KW - Safety

KW - Yeast

UR - http://www.scopus.com/inward/record.url?scp=84987837825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987837825&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84987837825

VL - 44

SP - 1037

EP - 1052

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

SN - 0386-3603

IS - 7

ER -